BIEL (BIEL) Stock Price & Analysis
BIEL (BIEL) rose 0.00% to USD 0 as of June 10, 2026 at 06:05 UTC, according to Nexqual real-time market data.
BIEL last closed at USD 0; the session ranged USD 0–0 on volume of 50,500 shares. Market capitalization is $8.65M, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 06:05 UTC.
Key Statistics (as of June 10, 2026 at 06:05 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 50,500 shares |
| Market Cap | $8.65M |
| Exchange | PNK |
Technical Analysis (BIEL)
Nexqual's technical model rates BIEL "STRONG SELL" based on 0 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 06:05 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.33 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (BIEL)
Wall Street analysts rate BIEL "None", per Nexqual as of June 10, 2026 at 06:05 UTC.
| Consensus Rating | None |
|---|
Earnings (BIEL)
Source: Nexqual, June 10, 2026 at 06:05 UTC.
Financials & Fundamentals (BIEL)
| Total Revenue | $1.61M |
|---|---|
| Revenue Growth (YoY) | -65.10% |
| Gross Margin | +49.43% |
| Operating Margin | -22.19% |
| Profit Margin | -18.01% |
| Current Ratio | 0.01 |
| Total Cash | $925 |
| Total Debt | $13.34M |
| Free Cash Flow | $-554,294 |
Source: Nexqual, June 10, 2026 at 06:05 UTC.
Financial Health Score (BIEL)
Nexqual rates BIEL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:05 UTC.
| Growth | Critical — Revenue -65% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $925 cash vs $13M debt |
| Cash Flow | Weak — FCF negative: -$554K, burning cash |
| Efficiency | Mixed — No data |
Ownership (BIEL)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 24.71B |
Source: Nexqual, June 10, 2026 at 06:05 UTC.
Leadership (BIEL)
BIEL is led by Kelly A. Whelan, CEO, President, Treasurer & Executive Director, per Nexqual as of June 10, 2026 at 06:05 UTC.
| CEO, President, Treasurer & Executive Director | Kelly A. Whelan |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LLBO | Lifeline BioTechnologies, Inc. | USD 0 | ▲ 40% |
| HTDS | HARD TO TREAT DISEASES INC | USD 0 | ▲ 0% |
| ASFX | AMERICAN SCIENTIFIC RESOURCES I | USD 0 | ▲ 0% |
| HBRM | Herborium Group, Inc. | USD 0 | ▲ 0% |
| BYOC | Beyond Commerce, Inc. | USD 0 | ▼ 100% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:05 UTC. This page is informational and not investment advice.